Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation

详细信息    查看全文

• 作者：Jingang An ; Zhengxiao Li ; Yingying Dong ; Jianwen Ren…
• 关键词：Amentoflavone ; Psoriasis ; Inflammation ; Keratinocyte proliferation ; NF ; κB
• 刊名：Molecular and Cellular Biochemistry
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：413
• 期：1-2
• 页码：87-95
• 全文大小：4,999 KB
• 参考文献：1.Naldi L (2004) Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 3:121–128CrossRef PubMed
  2.Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496–509CrossRef PubMed
  3.Raychaudhuri SP, Farber EM (2001) The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 15:16–17CrossRef PubMed
  4.Harden JL, Krueger JG, Bowcock AM (2015) The immunogenetics of Psoriasis: a comprehensive review. J Autoimmun 64:66–73CrossRef PubMed
  5.Lønnberg AS, Skov L, Duffy DL, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF (2015) Genetic factors explain variation in the age at onset of psoriasis: a population-based twin study. Acta Derm Venereol. doi:10.​2340/​00015555-2171
  6.Park BS, Youn JI (1998) Factors influencing psoriasis: an analysis based upon the extent of involvement and clinical type. J Dermatol 25:97–102CrossRef PubMed
  7.Perera GK, Di Meglio P, Nestle FO (2012) Psoriasis. Annu Rev Pathol 7:385–422CrossRef PubMed
  8.Gottlieb AB, Armstrong AW (2013) Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting. J Rheumatol 40:1428–1433CrossRef PubMed
  9.Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J (2008) Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 216:152–155CrossRef PubMed
  10.Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829–835CrossRef PubMed
  11.Kastelan M, Prpic-Massari L, Brajac I (2009) Apoptosis in psoriasis. Acta Dermatovenerol Croat 17:182–186PubMed
  12.Weatherhead SC, Farr PM, Jamieson D, Hallinan JS, Lloyd JJ, Wipat A, Reynolds NJ (2011) Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. J Invest Dermatol 131:1916–1926PubMedCentral CrossRef PubMed
  13.Tiberio R, Bozzo C, Pertusi G, Graziola F, Gattoni M, Griffanti P, Boggio P, Colombo E, Leigheb G (2009) Calcipotriol induces apoptosis in psoriatic keratinocytes. Clin Exp Dermatol 34:e972–e974CrossRef PubMed
  14.Grine L, Dejager L, Libert C, Vandenbroucke RE (2015) An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17. Cytokine Growth Factor Rev 26:25–33CrossRef PubMed
  15.Wagner EF, Schonthaler HB, Guinea-Viniegra J, Tschachler E (2010) Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol 6:704–714CrossRef PubMed
  16.Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352:1899–1912CrossRef PubMed
  17.Huang N, Rizshsky L, Hauck CC, Nikolau BJ, Murphy PA, Birt DF (2012) The inhibition of lipopolysaccharide-induced macrophage inflammation by 4 compounds in Hypericum perforatum extract is partially dependent on the activation of SOCS3. Phytochemistry 76:106–116PubMedCentral CrossRef PubMed
  18.Tsai SC, Liang YH, Chiang JH, Liu FC, Lin WH, Chang SJ, Lin WY, Wu CH, Weng JR (2012) Anti-inflammatory effects of Calophyllum inophyllum L. in RAW264.7 cells. Oncol Rep 28:1096–1102PubMed
  19.Woo ER, Lee JY, Cho IJ, Kim SG, Kang KW (2005) Amentoflavone inhibits the induction of nitric oxide synthase by inhibiting NF-kappaB activation in macrophages. Pharmacol Res 51:539–546CrossRef PubMed
  20.Banerjee T, Valacchi G, Ziboh VA, van der Vliet A (2002) Inhibition of TNFalpha-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-kappaB activation in A549 cells. Mol Cell Biochem 238:105–110CrossRef PubMed
  21.Nadeem A, Al-Harbi NO, Al-Harbi MM, El-Sherbeeny AM, Ahmad SF, Siddiqui N, Ansari MA, Zoheir KM, Attia SM, Al-Hosaini KA, Al-Sharary SD (2015) Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. Pharmacol Res 99:248–257CrossRef PubMed
  22.Zhao Y, Sun J, Dou W, Hu JH (2015) Curcumin inhibits proliferation of interleukin-22-treated HaCaT cells. Int J Clin Exp Med 8:9580–9584PubMedCentral PubMed
  23.Kjaer TN, Thorsen K, Jessen N, Stenderup K, Pedersen SB (2015) Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice. PLoS One 10:e126599CrossRef
  24.Nograles KE, Davidovici B, Krueger JG (2010) New insights in the immunologic basis of psoriasis. Semin Cutan Med Surg 29:3–9PubMedCentral CrossRef PubMed
  25.Guruvayoorappan C, Kuttan G (2008) Inhibition of tumor specific angiogenesis by amentoflavone. Biochemistry (Mosc) 73:209–218CrossRef
  26.Kang DG, Yin MH, Oh H, Lee DH, Lee HS (2004) Vasorelaxation by amentoflavone isolated from Selaginella tamariscina. Planta Med 70:718–722CrossRef PubMed
  27.Lin YM, Anderson H, Flavin MT, Pai YH, Mata-Greenwood E, Pengsuparp T, Pezzuto JM, Schinazi RF, Hughes SH, Chen FC (1997) In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora. J Nat Prod 60:884–888CrossRef PubMed
  28.Mora A, Paya M, Rios JL, Alcaraz MJ (1990) Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. Biochem Pharmacol 40:793–797CrossRef PubMed
  29.Zhang Z, Sun T, Niu JG, He ZQ, Liu Y, Wang F (2015) Amentoflavone protects hippocampal neurons: anti-inflammatory, antioxidative, and antiapoptotic effects. Neural Regen Res 10:1125–1133PubMedCentral CrossRef PubMed
  30.van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182:5836–5845CrossRef PubMed
  31.Van Belle AB, de Heusch M, Lemaire MM, Hendrickx E, Warnier G, Dunussi-Joannopoulos K, Fouser LA, Renauld JC, Dumoutier L (2012) IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol 188:462–469CrossRef PubMed
  32.Liu Y, Yang G, Zhang J, Xing K, Dai L, Cheng L, Liu J, Deng J, Shi G, Li C, Su X, Zhang S, Yang Y, Li J, Yu D, Xiang R, Wei Y, Deng H (2015) Anti-TNF-alpha monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis. Int Immunopharmacol 28:731–743CrossRef PubMed
  33.Sakthivel KM, Guruvayoorappan C (2013) Amentoflavone inhibits iNOS, COX-2 expression and modulates cytokine profile, NF-kappaB signal transduction pathways in rats with ulcerative colitis. Int Immunopharmacol 17:907–916CrossRef PubMed
  34.Lee JS, Lee MS, Oh WK, Sul JY (2009) Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells. Biol Pharm Bull 32:1427–1432CrossRef PubMed
  35.Lee SJ, Choi JH, Son KH, Chang HW, Kang SS, Kim HP (1995) Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids. Life Sci 57:551–558CrossRef PubMed
  36.Siveen KS, Kuttan G (2011) Effect of amentoflavone, a phenolic component from Biophytum sensitivum, on cell cycling and apoptosis of B16F-10 melanoma cells. J Environ Pathol Toxicol Oncol 30:301–309CrossRef PubMed
  37.Lee S, Kim H, Kang JW, Kim JH, Lee DH, Kim MS, Yang Y, Woo ER, Kim YM, Hong J, Yoon DY (2011) The biflavonoid amentoflavone induces apoptosis via suppressing E7 expression, cell cycle arrest at sub-G(1) phase, and mitochondria-emanated intrinsic pathways in human cervical cancer cells. J Med Food 14:808–816CrossRef PubMed
  38.Yan S, Xu Z, Lou F, Zhang L, Ke F, Bai J, Liu Z, Liu J, Wang H, Zhu H, Sun Y, Cai W, Gao Y, Su B, Li Q, Yang X, Yu J, Lai Y, Yu XZ, Zheng Y, Shen N, Chin YE, Wang H (2015) NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nat Commun 6:7652PubMedCentral CrossRef PubMed
  39.Hong KK, Gwak MJ, Song J, Kim NI (2015) NF-kappaB pathway activation and PTEN downregulation in psoriasis. Br J Dermatol. doi:10.​1111/​bjd.​14106
  
• 作者单位：Jingang An (1)
  Zhengxiao Li (1)
  Yingying Dong (1)
  Jianwen Ren (1)
  Jia Huo (1)
  
  1. Department of Dermatology, The Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, 710004, Shaanxi, People’s Republic of China
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Life Sciences
  Biochemistry
  Medical Biochemistry
  Oncology
  Cardiology
  
• 出版者：Springer Netherlands
• ISSN：1573-4919

文摘

Psoriasis is a one of the most common chronic skin diseases, which affects 0.6–4.8 % of the general population. Amentoflavone (AMF) belongs to the biflavonoid class of flavonoids, possessing various biological effects, such as anti-inflammatory, antioxidant, and anti-apoptotic effects. In the present study, we aimed to investigate the effect of AMF on psoriasis in imiquimod (IMQ) psoriasis-like lesions in mice and keratinocyte proliferation in HaCaT cells. We showed that AMF reduced skinfold thickening, and improved erythema and scaling scores and histological lesions in IMQ-treated mice. AMF exerted potent anti-inflammatory effect via influencing a variety of proinflammatory cytokines, including tumor necrosis factor α, interleukin (IL)-17A, IL-22, and IL-23 in local skin lesions and the whole body. In M5 (a cocktail of cytokines)-treated HaCaT cells, AMF significantly inhibited cell proliferation, promoted apoptosis, and inhibited the increase of expression of cyclin D1, cyclin E, IL-17A, and IL-22. In addition, AMF inhibited the upregulation of p65 NF-κB under psoriatic condition. Moreover, overexpression of p65 NF-κB significantly suppressed the effect of AMF on keratinocyte proliferation, apoptosis, and expression of cyclin D1, cyclin E, IL-17A, and IL-22. These results demonstrated that suppression of NF-κB was involved in AMF-resulted anti-proliferative, apoptosis-promoting, anti-inflammatory effects in keratinocytes. The data demonstrate that AMF may serve as potential therapeutic option for patients with psoriasis. Keywords Amentoflavone Psoriasis Inflammation Keratinocyte proliferation NF-κB